FDA

Latest Stories

Registered nurse Andraya Zelle treats a patient in the COVID intensive care unit at UW Medical Center-Montlake in Seattle. (AP Photo/Elaine Thompson, File)

Pfizer to seek FDA authorization of COVID-19 pill by Thanksgiving

By Tom Howell Jr. - The Washington Times

This October 2021, photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The U.S. moved a step closer to expanding vaccinations for millions more children as a panel of government advisers on Tuesday, Oct. 26, endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. (Pfizer via AP, File)

FDA authorizes Pfizer vaccine for ages 5-11

By Tom Howell Jr. - The Washington Times

This October 2021 photo provided by Pfizer shows boxes of kid-size doses of its COVID-19 vaccine. The U.S. moved a step closer to expanding vaccinations for millions more children as a panel of government advisers on Tuesday, Oct. 26, endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. (Pfizer via AP)

Teachers’ unions hail progress in COVID-19 vaccine for kids

By Tom Howell Jr. - The Washington Times

This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday, Oct. 22, as the U.S. considers opening vaccinations to that age group. (Pfizer via AP)

FDA panel recommends COVID-19 vaccine for ages 5-11

By Tom Howell Jr. - The Washington Times

A health care worker receives a Pfizer COVID-19 booster shot at Jackson Memorial Hospital Tuesday, Oct. 5, 2021, in Miami. (AP Photo/Lynne Sladky) ** FILE **

CDC panel advances plan for mix-and-match booster vaccines for COVID-19

By Tom Howell Jr. - The Washington Times

FILE - This Dec. 23, 2020 file photo shows a vial of the Moderna COVID-19 vaccine in the first round of staff vaccinations at a hospital in Denver. Federal regulators are expected to authorize the mixing and matching of COVID-19 booster shots this week in an effort to provide flexibility for those seeking to maintain protection against the coronavirus. The upcoming announcement by the Food and Drug Administration is likely to come along with authorization for boosters of the Moderna and Johnson &amp; Johnson shots. (AP Photo/David Zalubowski, File)

FDA official: Booster announcements coming Wednesday

By Matthew Perrone and Lauran Neergaard - Associated Press

In this Dec. 10, 2020, file photo, a sign is displayed for the Food and Drug Administration in Silver Spring, Md. (AP Photo/Manuel Balce Ceneta, File) **FILE**

FDA approves J&J and Moderna boosters, mixing vaccines

By Tom Howell Jr. - The Washington Times

In this Aug. 28, 2021, photo, Mayra Navarrete, 13, receives the Pfizer COVID-19 vaccine from registered nurse, Noleen Nobleza at a clinic set up in the parking lot of CalOptima in Orange, Calif. With more than 40 million doses of coronavirus vaccines available, U.S. health authorities said they're confident both seniors and other vulnerable Americans seeking booster shots and parents anticipating approval of initial shots for young children will have easy access. (AP Photo/Jae C. Hong) **FILE**

WH touts plan to get kids ages 5 to 11 vaccinated for COVID-19

By Tom Howell Jr. - The Washington Times

Health and Human Services Secretary Xavier Becerra holds a mask as he testifies during a Senate Health, Education, Labor, and Pensions Committee hearing to discuss reopening schools during the COVID-19 pandemic on Thursday, Sept. 30, 2021, at Capitol Hill in Washington. (Greg Nash/Pool via AP) ** FILE **

FDA moves to offer hearing aids over the counter

By Tom Howell Jr. - The Washington Times

In this Oct. 5, 2021, file photo, a health care worker receives a Pfizer COVID-19 booster shot at Jackson Memorial Hospital in Miami. The number of Americans getting COVID-19 vaccines has steadily increased to a three-month high as seniors and people with medical conditions seek boosters, and government and employer mandates push more workers to take their first doses. (AP Photo/Lynne Sladky, File)

FDA eyeing plan to allow mix-and-match of COVID-19 vaccine booster, report says

By Tom Howell Jr. - The Washington Times

FDA panel takes up tough questions on J&J COVID-19 boosters

By Matthew Perrone and Lauran Neergaard - Associated Press

This Jan. 23, 2014, photo shows the nutrition facts label on the side of a cereal box in Washington. Food companies are coming under renewed pressure to use less salt after U.S. regulators spelled out target sodium levels for dozens of foods including condiments, french fries and potato chips. (AP Photo/J. David Ake) **FILE**

FDA sets new goals to cut salt in food industry

By Shen Wu Tan - The Washington Times

In this May 19, 2021, file photo, a licensed practical nurse draws a Moderna COVID-19 vaccine into a syringe at a mass vaccination clinic at Gillette Stadium in Foxborough, Mass. Starting Thursday, Oct. 14, 2021, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra shots of Moderna or Johnson &amp; Johnson vaccines should be dispensed and, if so, who should get them and when. (AP Photo/Steven Senne, File)

Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines

By Lauran Neergaard and Matthew Perrone - Associated Press

This undated image provided by Merck &amp; Co. shows their new antiviral medication. The drugmaker has said its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths. (Merck &amp; Co. via AP)

Merck asks U.S. FDA to authorize promising anti-COVID pill

By Matthew Perrone - Associated Press

FILE- In this Dec. 10, 2020, file photo, a sign is displayed for the Food and Drug Administration in Silver Spring, Md. After nearly nine months of searching, President Joe Biden says he’s close to naming his choice to lead the FDA, which oversees vaccines, drugs and tests. (AP Photo/Manuel Balce Ceneta, File)

New FDA chief can’t come soon enough for beleaguered agency

By Matthew Perrone - Associated Press

Nurse practitioners Taryn McCoy, left, and Gina LaFountain take inventory of supplies in the intensive care ward, one of four wards that are part of the 32-bed Samaritan's Purse Emergency Field Hospital set up in one of the University of Mississippi Medical Center's parking garages, Tuesday, Aug. 17, 2021, in Jackson, Miss. The field hospital joins a 20-bed field hospital and monoclonal antibody clinic opened by the U.S. Department of Health and Human Services at UMMC in response to the rising number of COVID-19 cases in the state. (AP Photo/Rogelio V. Solis) ** FILE **

Pack of pills, preventive antibodies add to arsenal of COVID-19 treatments

By Shen Wu Tan and Tom Howell Jr. - The Washington Times

A medical worker prepares a shot of Pfizer COVID-19 vaccine, at Belgrade Fair makeshift vaccination center, Serbia, Saturday, Oct. 2, 2021. (AP Photo/Darko Vojinovic)

Pfizer scientists tout natural immunity in Project Veritas sting: ‘Antibodies are probably better’

By Valerie Richardson - The Washington Times

In this July 20, 2021 file photo, top infectious disease expert Dr. Anthony Fauci testifies before the Senate Health, Education, Labor, and Pensions Committee, on Capitol Hill in Washington. (AP Photo/J. Scott Applewhite, Pool) **FILE**

Fauci hopes to start vaccinating kids 5-11 next month; new poll shows voters wary

By Valerie Richardson - The Washington Times

In this Tuesday, Aug. 31, 2021, file photo, Ann Enderle, R.N., attends to a COVID-19 patient in the Medical Intensive care unit (MICU) at St. Luke's Boise Medical Center in Boise, Idaho. Idaho's public health officials say crisis standards of care are &quot;imminent&quot; for the state's most populated region as hospitals in the Boise area continue to be overrun with unvaccinated coronavirus patients. Hospitals in the northern half of the state were given permission to begin rationing care last week. (AP Photo/Kyle Green, File)

Delta surge drove recent vaccinations; recipients cite hospitalization or death of a friend: Poll

By Tom Howell Jr. - The Washington Times

In this Jan. 8, 2021, file photo, a pharmacist prepares a syringe of the Pfizer vaccine for COVID-19, at Queen Anne Healthcare, a skilled nursing and rehabilitation facility in Seattle. The U.S. vaccination drive against COVID-19 stood on the verge of a major new phase as government advisers Thursday, Sept. 23, recommended booster doses of Pfizer's vaccine for millions of older or otherwise vulnerable Americans despite doubts the extra shots will do much to slow the pandemic. (AP Photo/Ted S. Warren, File)

CDC panel backs COVID-19 boosters for seniors, those with underlying conditions

By Shen Wu Tan and Tom Howell Jr. - The Washington Times